newsletter masthead
December 20, 2018
Dr. Stan Gerson Stan Gerson, MD
Director, Case Comprehensive Cancer Center
Thank You and Best Wishes to Li
The Case Comprehensive Cancer Center (Case CCC) thanks Li Li, MD, PhD, MPH for his leadership and dedication to our mission since joining the center in the early 2000s.

Li Li, MD, PhD
Dr.  Li started his professional career as a lecturer in China, then moved to the United States where he was a research assistant at USC before pursuing his medical residency at the University of Kentucky. He settled in at Case Western Reserve University (CWRU) in 2000 and soon became an important part of our Center. His professional appointments and leadership experiences only expanded alongside his clinical responsibilities at University Hospitals Cleveland Medical Center over the past 18 years and we are grateful for his time spent with us. His is an example of career building at its best!

From 2001 to 2006, Dr. Li was a Damon Runyon-Lilly Clinical Investigator, establishing a large genetic epidemiology study of colon cancer to investigate complex gene-environment interactions. His research interests involve cancer, molecular/genetic epidemiology and disease prevention and the NCI has continuously funded his efforts. Dr. Li has made significant contribution to the Oxford University-led international consortium for Colon Cancer Gene Discovery (CoGENT), and the USC-led Colorectal Transdisciplinary Study (CORECT) consortium. Since 2005, Dr. Li has served as Co-Director for the highly successful R25 Computational Genomic Epidemiology of Cancer (CoGEC) training program. A number of faculty are graduates of this successful program.  He was appointed acting and then fully chartered Associate Director for Cancer Prevention Research at the Case CCC in 2007, where he oversaw and promoted research across all aspects of population sciences. In 2015, Dr. Li also became the director and endowed chair of the Mary Ann Swetland Center for Environmental Health at CWRU SOM. His work has focused on gene environment interactions, he has been a major contributor to the GI-SPORE, has focused on development and monitoring of cohorts for colon cancer and breast cancer risk and screening, and in linking population-based issues detected by geo-coding with disease and cancer risk.  He has been highly collaborative.  As a member of the Case CCC Executive Committee, Dr. Li contributed heavily to several CCSG renewals and led the integration of population sciences across our scientific programs. He is also a PI of the recently awarded multi-PI Cancer Disparities pre-SPORE P20 team, along with Drs. Monica Webb Hooper and Nate Berger.

In January, Dr. Li is relocating to the University of Virginia. He will be missed for his research expertise, leadership and mentorship. Thank you, Dr. Li!
Deadline Approaching: Submit Abstracts for 3rd Annual Cancer Disparities Symposium
This Friday, December 21 is the deadline to submit abstracts for the 3rd Annual Cancer Disparities Symposium, Eliminating Cancer Disparities: Staying the Course Toward Collective Impact.  Abstracts are due via email to  by 5pm EST. 

The Office of Cancer Disparities Research at the  Case Comprehensive Cancer Center  
invites multidisciplinary researchers, community agencies and organizations to submit abstracts for presentation at the 3rd Annual Cancer Disparities Symposium. Abstracts will be divided into two tracks:   Scientific Research  and  Community Programs .  
This call for abstracts is an opportunity to highlight community and/or wellness programs on topics related to cancer disparities, and provide a forum to showcase the breadth and depth of work happening in our community. Meritorious abstracts will be selected for oral presentations. 

Students who submit an abstract are able to register for FREE! Submit your abstract to  BEFORE registering. You will be emailed a discount code to be entered on the registration form so that you receive the discount. 

2019 Symposium Highlights
  • Eliseo J. Pérez-Stable, MD, Director, National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH), will discuss cancer disparities research trends and funding opportunities. 
  • Rick Kittles, PhD, Associate Director of Health Equities at City of Hope, will give a research-focused presentation on cancer disparities research. 
  • An entire afternoon session is devoted to research aligned with abstract submissions; this includes oral presentations from selected abstracts, plus a poster session. Students who submit an abstract can attend this symposium free of charge. 
  • The audience for this symposium is diverse in background and field, allowing attendees to interact, network, and expand their knowledge and opportunities for collaboration.
Plans for NCI's Fiscal Year 2019 Budget from NCI Director Dr. Ned Sharpless
On Tuesday, Dr. Sharpless provided an overview of the how FY 2019 resources will be allocated in alignment of three core principles:
  • Increase support for cancer research through research project grants (RPGs)
  • Stay true to the vision of the Cancer Moonshot
  • Prioritize training and supporting early-stage investigators to ensure a robust cancer research workforce pipeline
Cancer Center Seminar Series Winter Break
Case Western Reserve University and the Case Comprehensive Cancer Center will be closed Monday December 24, 2018 through January 1, 2019 for Winter Break. The Cancer Center Seminar Series will resume Friday, January 11, 2019.  Click here for a list of upcoming seminars.
AICR Investigator-Initiated Research Grant Program
LOI Deadline: Jan 25, 2019

The American Institute for Cancer Research Investigator-Initiated Research Grant Program
AICR logowelcomes proposals for research addressing the effects of diet, nutrition, body composition and physical activity on cancer risk and outcomes. Click here for more information on research areas, principles and themes, as well as eligibility criteria and other guidelines for your letter.
Call for Proposals: American Thyroid Association Research Grants
Deadline: Jan 28, 2019

The American Thyroid Association (ATA) is pleased
to announce the availability of funds to support new investigator initiated research projects in the areas of thyroid function, thyroid disease, and thyroid cancer. The call for proposals notes the research awards are targeted for funding of new investigators, US or international, and intended to assist in obtaining preliminary data for submission of a more substantial application (e.g. to the National Institutes of Health (NIH)). Research grants, up to $25,000 annually, will be awarded for up to two year terms. Applications are open now.
Leukemia Research Foundation Research Grants
LOI Deadline: Feb 1, 2019

The Leukemia Research Foundation funds new investigators, those beginning to establish their own laboratories and no longer under the tutelage of a senior scientist mentor, and is accepting Letters of Intent for its Hollis Brownstein Research Grants Program. The one-year, $100,000 grants will be awarded in support of innovative blood cancer research projects with priority to proposals focusing on leukemia, lymphoma, MDS and multiple myeloma. more>
Newswise - Nov 26, 2018
A recent study co-authored by Cleveland Clinic hematologist-oncologist and Case CCC member  Brian Rini, MD notes that checkpoint inhibitors have led to "remarkable progress" as well as need for greater integration of care.

Washington Times - Dec 5, 2018
"This is the first publication in the field to specifically address the question" why HIV-positive patients develop specific types of cancer and when, said Ge Jin, PhD lead author of the study, associate professor in the Department of Biological Sciences at Case Western Reserve University School of Dental Medicine and member, Case CCC.

Fox 8 Cleveland - Dec 11, 2018
University Hospitals hematology and oncology specialist Paolo Caimi, MD explains how the patient's cells are "modified with a particular virus to introduce a genetic modification over twelve to 14 days" with CAR T-cell Therapy. Dr. Caimi is a member of the Case CCC's Hematopoietic and Immune Cancer Biology Program.

CWRU's The Daily - Dec 18, 2018
Scientists in the computational imaging lab of  Case CCC member  Anant Madabhushi, PhD have started thinking outside the box-or in their case, looking outside the tumor. The researchers have used a computer to analyze the regions outside the tumor and blood vessels nearby to successfully predict whether suspicious-looking nodules are cancerous, allowing for non-invasive analysis.
NIH BULLETIN - Notices and Funding Opportunities
Notice of Change in Expiration Date of PA-17-278 "HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)"

Notice of Change in Expiration Date of PA-17-280 "In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)"

Thurs, Dec 20
Molecular Biology and Microbiology Seminar
Marie McCausland and Braulio Llorens
Levine lab, CWRU
1p SOM W203
Fri, Dec 21
Taussig Cancer Institute Grand Rounds
8a CA5-120
Mon, Dec 24 - Tues, Jan 1
Case Western Reserve University and Case Comprehensive Cancer Center Closed for Winter Break
Thurs, Jan 3
Developmental Therapeutics Journal Club
9a N E 6-218
Fri, Jan 4
Taussig Cancer Institute Grand Rounds
8a CA5-120
Mon, Jan 7
Cancer Center Research Chalk Talk
1p WRB 3-136

Tumor Immunology and Immunotherapy Meeting
4p CA5-124
Tues, Jan 8
Molecular Biology and Microbiology Seminar
1p SOM W203
Weds, Jan 9
Molecular Biology and Microbiology Seminar
5p WRT 206
Thurs, Jan 10
Developmental Therapeutics Journal Club
9a N E 6-218

Molecular Biology and Microbiology Seminar
1p SOM W203
Fri, Jan 11
Taussig Cancer Institute Grand Rounds
8a CA5-120

Cancer Center Seminar Series
David Avigan, MD
Chief, Section of Hematological Malignancies and Bone Marrow Transplantation,  Beth Israel Deaconess Medical Center
Professor of Medicine, Harvard Medical School
12p WRB Auditorium

Deadline: Open

Deadline: Open

Deadline: Open
Case Comprehensive Cancer Center